Myasthenic crisis in COVID-19

The neurotropic potential and the neurological complications of coronavirus disease (COVID-19) are still being uncovered, those documented so far include headaches, acute cerebrovascular incidents, anosmia, post-infectious disseminated and brainstem encephalitis and viral meningitis [1] and Guillain-Barr é Syndrome [2]. Myasthenia gravis (MG) patients are particularly susceptible to infections causing crises due to the combination of reduced neuromuscular safety factors adversely affected by pyrexia and the effect of acute inflammatory mediators compounded by immunosuppression in many patients [3,4 ].
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Tags: Letter to the Editor Source Type: research